User profiles for Marcus Lacerda

Marcus Vinícius Guimarães de Lacerda

Fiocruz
Verified email at fiocruz.br
Cited by 18559

Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb …

…, MS Xavier, WM Monteiro, MVG Lacerda - Clinical Infectious …, 2021 - academic.oup.com
Background Steroid use for coronavirus disease 2019 (COVID-19) is based on the possible
role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by …

Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS …

…, WM Monteiro, MVG Lacerda - JAMA network …, 2020 - jamanetwork.com
Importance There is no specific antiviral therapy recommended for coronavirus disease 2019
(COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ…

[HTML][HTML] Malaria in Brazil: an overview

J Oliveira-Ferreira, MVG Lacerda, P Brasil… - Malaria journal, 2010 - Springer
Malaria is still a major public health problem in Brazil, with approximately 306 000 registered
cases in 2009, but it is estimated that in the early 1940s, around six million cases of malaria …

[HTML][HTML] A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms

…, PG Kremsner, M Lacerda… - … England Journal of …, 2016 - Mass Medical Soc
Background Recent gains in reducing the global burden of malaria are threatened by the
emergence of Plasmodium falciparum resistance to artemisinins. The discovery that mutations …

On the Cytoadhesion of Plasmodium vivax–Infected Erythrocytes

…, G Wunderlich, MVG Lacerda… - The Journal of …, 2010 - academic.oup.com
Background. Plasmodium falciparum and Plasmodium vivax are responsible for most of the
global burden of malaria. Although the accentuated pathogenicity of P. falciparum occurs …

[HTML][HTML] COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases

…, WM Monteiro, MVG Lacerda - Revista da Sociedade …, 2020 - SciELO Brasil
The outbreak of new coronavirus disease 2019 (COVID-19) reported for the first time in Wuhan,
China in late December 2019 have rapidly spread to other countries and it was declared …

Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase IIb, placebo-controlled trial

…, MS Xavier, WM Monteiro, MVG Lacerda - 2020 - arca.fiocruz.br
Background: Steroid use for COVID-19 is based on the possible role of these drugs in
mitigating the inflammatory response, mainly in the lungs, triggered by SARS-CoV-2. This study …

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b …

A Llanos-Cuentas, MV Lacerda, R Rueangweerayut… - The Lancet, 2014 - thelancet.com
Background Clinical effectiveness of previous regimens to treat Plasmodium vivax infection
have been hampered by compliance. We aimed to assess the dose–response, safety, and …

[HTML][HTML] Thrombocytopenia in malaria: who cares?

MVG Lacerda, MPG Mourão, HCC Coelho… - Memorias do Instituto …, 2011 - SciELO Brasil
Despite not being a criterion for severe malaria, thrombocytopenia is one of the most
common complications of both Plasmodium vivax and Plasmodium falciparum malaria. In a …

[HTML][HTML] Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination

…, WM Monteiro, SM Herrera, S Herrera, MVG Lacerda - Malaria journal, 2017 - Springer
In spite of significant progress towards malaria control and elimination achieved in South
America in the 2000s, this mosquito-transmitted tropical disease remains an important public …